These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 3138406)

  • 1. Midazolam and discriminative motor control: chronic administration, withdrawal and modulation by the antagonist Ro 15-1788.
    Tang M; Lau CE; Falk JL
    J Pharmacol Exp Ther; 1988 Sep; 246(3):1053-60. PubMed ID: 3138406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Motor performance decrement by midazolam: antagonism by Ro 15-1788 and CGS 8216.
    Lau CE; Falk JL; Tang M
    Pharmacol Biochem Behav; 1990 May; 36(1):139-43. PubMed ID: 2112257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diazepam and discriminative motor control: acute, chronic and withdrawal effects.
    Culberson JW; Tang M; Lau CE; Falk JL
    Pharmacol Biochem Behav; 1990 Feb; 35(2):419-27. PubMed ID: 2320651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereoselective discriminative stimulus effects of zopiclone in rhesus monkeys.
    McMahon LR; Jerussi TP; France CP
    Psychopharmacology (Berl); 2003 Jan; 165(3):222-8. PubMed ID: 12434260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flumazenil discrimination by humans under a two-response and a novel-response procedure.
    Smith BJ; Bickel WK
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1257-68. PubMed ID: 10565850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerance, cross-tolerance and withdrawal in rats made dependent on diazepam.
    Pugh SL; Boone MS; Emmett-Oglesby MW
    J Pharmacol Exp Ther; 1992 Aug; 262(2):751-8. PubMed ID: 1501120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the behavioral effects of bretazenil and flumazenil in triazolam-dependent and non-dependent baboons.
    Weerts EM; Ator NA; Kaminski BJ; Griffiths RR
    Eur J Pharmacol; 2005 Sep; 519(1-2):103-13. PubMed ID: 16129429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Midazolam withdrawal and discriminative motor control: effects of FG 7142 and Ro 15-1788.
    Vigorito M; Lau CE; Tang M; Falk JL
    Pharmacol Biochem Behav; 1991 Jun; 39(2):351-9. PubMed ID: 1658816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerance and physical dependence to a short-acting benzodiazepine, midazolam.
    Boisse NR; Quaglietta N; Samoriski GM; Guarino JJ
    J Pharmacol Exp Ther; 1990 Mar; 252(3):1125-33. PubMed ID: 2319464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potency of positive gamma-aminobutyric acid(A) modulators to substitute for a midazolam discriminative stimulus in untreated monkeys does not predict potency to attenuate a flumazenil discriminative stimulus in diazepam-treated monkeys.
    McMahon LR; Gerak LR; France CP
    J Pharmacol Exp Ther; 2001 Sep; 298(3):1227-35. PubMed ID: 11504825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of benzodiazepines on acute and chronic ethanol-induced nociception in rats.
    Gatch MB
    Alcohol Clin Exp Res; 1999 Nov; 23(11):1736-43. PubMed ID: 10591589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug discrimination analysis of midazolam under a three-lever procedure: I. Dose-dependent differences in generalization and antagonism.
    Sannerud CA; Ator NA
    J Pharmacol Exp Ther; 1995 Jan; 272(1):100-11. PubMed ID: 7815322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerance to caffeine-induced stimulation of locomotor activity in rats.
    Finn IB; Holtzman SG
    J Pharmacol Exp Ther; 1986 Aug; 238(2):542-6. PubMed ID: 3735131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic characterization of acute chlordiazepoxide dependence in the rat.
    Boisse NR; Periana RM; Guarino JJ; Kruger HS; Samoriski GM
    J Pharmacol Exp Ther; 1986 Dec; 239(3):775-83. PubMed ID: 3098961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerance to the discriminative stimulus effects of midazolam: evidence for environmental modification and dose fading.
    Sannerud CA; Griffiths RR
    Behav Pharmacol; 1993 Apr; 4(2):125-133. PubMed ID: 11224179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Assessment of the efficacy and tolerance of a benzodiazepine antagonist (Ro 15-1788)].
    Rouiller M; Forster A; Gemperle M
    Ann Fr Anesth Reanim; 1987; 6(1):1-6. PubMed ID: 3107442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apparent pA2 values of benzodiazepine antagonists and partial agonists in monkeys.
    Paronis CA; Bergman J
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1222-9. PubMed ID: 10454498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a specific benzodiazepine antagonist (RO 15-1788) on cerebral blood flow.
    Forster A; Juge O; Louis M; Nahory A
    Anesth Analg; 1987 Apr; 66(4):309-13. PubMed ID: 3105357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacodynamic modeling of the electroencephalographic effects of flumazenil in healthy volunteers sedated with midazolam.
    Fiset P; Lemmens HL; Egan TD; Shafer SL; Stanski DR
    Clin Pharmacol Ther; 1995 Nov; 58(5):567-82. PubMed ID: 7586951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Withdrawal from diazepam substitutes for the discriminative stimulus properties of pentylenetetrazol.
    Emmett-Oglesby MW; Mathis DA; Harris CM; Idemudia SO; Lal H
    J Pharmacol Exp Ther; 1988 Mar; 244(3):892-7. PubMed ID: 3150850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.